Adjuvant Therapy of Nivolumab Combined with Ipilimumab Versus Nivolumab Alone in Patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
- Creator: Weber, Jeffrey S. , Schadendorf, Dirk , Ascierto, Paolo A. , Sandhu, Shahneen , Eigentler, Thomas , Gutzmer, Ralf , Hassel, Jessica C. , Robert, Caroline , Carlino, Matteo S. , Di Giacomo, Anna Maria , Butler, Marcus O. , Muñoz-Couselo, Eva , Del Vecchio, Michele , Brown, Michael P. , Rutkowski, P , Haydon, A , Grob, J-J , Schachter, J , Queirolo, P , de la Cruz-Merino, L , van der Westhuizen, Andre , Menzies, AM , Re, S , Larkin, James , Bas, T , de Pril, V , Braverman, J , Tenney, DJ , Tang, H , Long, GV , Atkinson, Victoria , Schenker, Michael , Pigozzo, Jacopo , Gogas, Helen , Dalle, Stéphane , Meyer, Nicolas
- Resource Type: journal article
- Date: 2023
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with Carboplatin and Paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma
- Creator: Hauschild, Axel , Agarwala, Sanjiv S , Peschel, Christian , Schadendorf, Dirk , Garbe, Claus , O'Day, Steven , Daud, Adil , White, J. Michael , Xia, Chenghua , Patel, Kiran , Kirkwood, John M. , Keilholz, Ulrich , Trefzer, Uwe , Hogg, David , Robert, Caroline , Hersey, Peter , Eggermont, Alexander , Grabbe, Stephan , Gonzalez, Rene , Gille, Jens
- Resource Type: journal article
- Date: 2009